183 related articles for article (PubMed ID: 27939474)
1. Evaluation of fetal hypermethylated RASSF1A in pre-eclampsia and its relationship with placental protein-13, pregnancy associated plasma protein-A and urine protein.
Saraswathy S; Sahai K; Yadav TP; Arora D; Mendiratta SL; Naqvi SH; Biswas S; Krishnan M; Abraham KM
Pregnancy Hypertens; 2016 Oct; 6(4):306-312. PubMed ID: 27939474
[TBL] [Abstract][Full Text] [Related]
2. Fetal-specific hypermethylated RASSF1A quantification in pregnancy.
Saraswathy S; Sahai K; Arora D; Krishnan M; Mendiratta SL; Biswas S; Abraham KM
J Matern Fetal Neonatal Med; 2017 Apr; 30(7):849-853. PubMed ID: 27165812
[TBL] [Abstract][Full Text] [Related]
3. Association of fetal-derived hypermethylated RASSF1A concentration in placenta-mediated pregnancy complications.
Kim MJ; Kim SY; Park SY; Ahn HK; Chung JH; Ryu HM
Placenta; 2013 Jan; 34(1):57-61. PubMed ID: 23187089
[TBL] [Abstract][Full Text] [Related]
4. [Predictive value of placenta-derived RASSF1A sequence expression in maternal plasma for pre-eclampsia].
Wang J; Yang J; Wu X; Mu Y; Li S; Cui K; Wang X; Zhao F
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2014 Feb; 31(1):25-8. PubMed ID: 24510557
[TBL] [Abstract][Full Text] [Related]
5. Quantitative aberrations of hypermethylated RASSF1A gene sequences in maternal plasma in pre-eclampsia.
Tsui DW; Chan KC; Chim SS; Chan LW; Leung TY; Lau TK; Lo YM; Chiu RW
Prenat Diagn; 2007 Dec; 27(13):1212-8. PubMed ID: 17994635
[TBL] [Abstract][Full Text] [Related]
6. Hypermethylated RASSF1A in maternal plasma: A universal fetal DNA marker that improves the reliability of noninvasive prenatal diagnosis.
Chan KC; Ding C; Gerovassili A; Yeung SW; Chiu RW; Leung TN; Lau TK; Chim SS; Chung GT; Nicolaides KH; Lo YM
Clin Chem; 2006 Dec; 52(12):2211-8. PubMed ID: 17068167
[TBL] [Abstract][Full Text] [Related]
7. Feasibility of fetal-derived hypermethylated RASSF1A sequence quantification in maternal plasma--next step toward reliable non-invasive prenatal diagnostics.
Zejskova L; Jancuskova T; Kotlabova K; Doucha J; Hromadnikova I
Exp Mol Pathol; 2010 Dec; 89(3):241-7. PubMed ID: 20868679
[TBL] [Abstract][Full Text] [Related]
8. [Quantitative detection of the hypermethylated RASSF1A gene in maternal plasma of pre-eclampsia].
Wang J; Zhao F; Wu Y; Liu R; Mu Y
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Feb; 27(1):73-6. PubMed ID: 20140873
[TBL] [Abstract][Full Text] [Related]
9. Quantification and application of the placental epigenetic signature of the RASSF1A gene in maternal plasma.
Zhao F; Wang J; Liu R; Yang J; Cui K; Wu Y; Guo J; Mu Y; Wang X
Prenat Diagn; 2010 Aug; 30(8):778-82. PubMed ID: 20661892
[TBL] [Abstract][Full Text] [Related]
10. First-trimester maternal serum PP-13, PAPP-A and second-trimester uterine artery Doppler pulsatility index as markers of pre-eclampsia.
Spencer K; Cowans NJ; Chefetz I; Tal J; Meiri H
Ultrasound Obstet Gynecol; 2007 Feb; 29(2):128-34. PubMed ID: 17149788
[TBL] [Abstract][Full Text] [Related]
11. RASSF1A in maternal plasma as a molecular marker of preeclampsia.
Papantoniou N; Bagiokos V; Agiannitopoulos K; Kolialexi A; Destouni A; Tounta G; Kanavakis E; Antsaklis A; Mavrou A
Prenat Diagn; 2013 Jul; 33(7):682-7. PubMed ID: 23526657
[TBL] [Abstract][Full Text] [Related]
12. Quantification of extracellular DNA using hypermethylated RASSF1A, SRY, and GLO sequences--evaluation of diagnostic possibilities for predicting placental insufficiency.
Hromadnikova I; Zejskova L; Kotlabova K; Jancuskova T; Doucha J; Dlouha K; Krofta L; Jirasek JE; Vlk R
DNA Cell Biol; 2010 Jun; 29(6):295-301. PubMed ID: 20235876
[TBL] [Abstract][Full Text] [Related]
13. First-trimester placental protein 13 and placental growth factor: markers for identification of women destined to develop early-onset pre-eclampsia.
Wortelboer EJ; Koster MP; Cuckle HS; Stoutenbeek PH; Schielen PC; Visser GH
BJOG; 2010 Oct; 117(11):1384-9. PubMed ID: 20840693
[TBL] [Abstract][Full Text] [Related]
14. Can first trimester placental protein-13 and pregnancy-associated plasma protein-A predict pre-eclampsia in Turkish women?
Ceylan N; Ozaksit G; Unlu BS; Yildiz Y; Yilmaz S; Agaca F
J Obstet Gynaecol; 2014 Aug; 34(6):482-5. PubMed ID: 24786703
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of a novel assay for detection of the fetal marker RASSF1A: facilitating improved diagnostic reliability of noninvasive prenatal diagnosis.
White HE; Dent CL; Hall VJ; Crolla JA; Chitty LS
PLoS One; 2012; 7(9):e45073. PubMed ID: 23024794
[TBL] [Abstract][Full Text] [Related]
16. [Detection of fetal RASSF1A gene in maternal plasma for noninvasive prenatal diagnosis].
Ma L; Liu YC; Zheng L; Wu MH; Liu Y; Sun J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Oct; 21(5):1301-4. PubMed ID: 24156454
[TBL] [Abstract][Full Text] [Related]
17. Dynamic Changes of Fetal-Derived Hypermethylated RASSF1A and Septin 9 Sequences in Maternal Plasma.
Zhang L; Wang CM; Zhou WP; Chen QP; Zhou S; Lei W; Deng H; Zhang L; Liu GC
Reprod Sci; 2021 Apr; 28(4):1194-1199. PubMed ID: 33417202
[TBL] [Abstract][Full Text] [Related]
18. Non-invasive prenatal diagnosis of trisomy 21 by dosage ratio of fetal chromosome-specific epigenetic markers in maternal plasma.
Zhang M; Li T; Chen J; Li L; Zhou C; Wang Y; Liu W; Zhang Y
J Huazhong Univ Sci Technolog Med Sci; 2011 Oct; 31(5):687. PubMed ID: 22038362
[TBL] [Abstract][Full Text] [Related]
19. Prospective evaluation of RASSF1A cell-free DNA as a biomarker of pre-eclampsia.
Salvianti F; Inversetti A; Smid M; Valsecchi L; Candiani M; Pazzagli M; Cremonesi L; Ferrari M; Pinzani P; Galbiati S
Placenta; 2015 Sep; 36(9):996-1001. PubMed ID: 26183647
[TBL] [Abstract][Full Text] [Related]
20. Elevated plasma levels of hypermethylated RASSF1A gene sequences in pregnant women with intrahepatic cholestasis.
Yi P; Yin N; Zheng Y; Jiang H; Yu X; Yan Y; Liu Q; Xiao F; Li L
Cell Biochem Biophys; 2013; 67(3):977-81. PubMed ID: 23579583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
